XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Common Stock in Treasury
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning Balance at Dec. 31, 2023 $ 178,920 $ 253 $ (369,973) $ 336,938 $ (20,758) $ 232,460
Beginning balance (in shares) at Dec. 31, 2023     (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8,649)         (8,649)
Currency translation adjustment (1,591)       (1,591)  
Shares issued for employee benefit plan and compensation (in shares)   156,000        
Shares issued for employee benefit plan and compensation 301 $ 2   299    
Purchase of treasury shares (in shares)     (140,000)      
Purchase of treasury shares (1,230)   $ (1,230)      
Shares issued to directors (in shares)   6,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,904     1,904    
Ending balance (in shares) at Mar. 31, 2024   25,508,000        
Ending Balance at Mar. 31, 2024 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Ending balance (in shares) at Mar. 31, 2024     (12,600,000)      
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning Balance at Dec. 31, 2023 178,920 $ 253 $ (369,973) 336,938 (20,758) 232,460
Beginning balance (in shares) at Dec. 31, 2023     (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (19,500)          
Currency translation adjustment $ (2,293)          
Purchase of treasury shares (in shares) (201,000)          
Purchase of treasury shares $ (1,896)          
Ending balance (in shares) at Sep. 30, 2024   25,680,000        
Ending Balance at Sep. 30, 2024 161,186 $ 257 $ (371,869) 342,889 (23,051) 212,960
Ending balance (in shares) at Sep. 30, 2024     (12,660,000)      
Beginning balance (in shares) at Mar. 31, 2024   25,508,000        
Beginning Balance at Mar. 31, 2024 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Beginning balance (in shares) at Mar. 31, 2024     (12,600,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8,193)         (8,193)
Currency translation adjustment (2,902)       (2,902)  
Shares issued for employee benefit plan and compensation (in shares)   111,000        
Shares issued for employee benefit plan and compensation 362 $ 1   361    
Purchase of treasury shares (in shares)     (55,000)      
Purchase of treasury shares (611)   $ (611)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,460     1,460    
Ending balance (in shares) at Jun. 30, 2024   25,627,000        
Ending Balance at Jun. 30, 2024 159,771 $ 256 $ (371,814) 340,962 (25,251) 215,618
Ending balance (in shares) at Jun. 30, 2024     (12,655,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,658)         (2,658)
Currency translation adjustment 2,200       2,200  
Shares issued for employee benefit plan and compensation (in shares)   45,000        
Shares issued for employee benefit plan and compensation 277 $ 1   276    
Purchase of treasury shares (in shares)     (5,000)      
Purchase of treasury shares (55)   $ (55)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,651     1,651    
Ending balance (in shares) at Sep. 30, 2024   25,680,000        
Ending Balance at Sep. 30, 2024 161,186 $ 257 $ (371,869) 342,889 (23,051) 212,960
Ending balance (in shares) at Sep. 30, 2024     (12,660,000)      
Beginning balance (in shares) at Dec. 31, 2024   25,713,000        
Beginning Balance at Dec. 31, 2024 $ 153,105 $ 257 $ (371,930) 344,697 (28,350) 208,431
Beginning balance (in shares) at Dec. 31, 2024 (12,666,443)   (12,666,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (6,274)         (6,274)
Currency translation adjustment 1,578       1,578  
Shares issued for employee benefit plan and compensation (in shares)   124,000        
Shares issued for employee benefit plan and compensation 159 $ 1   158    
Purchase of treasury shares (in shares)     (41,000)      
Purchase of treasury shares (383)   $ (383)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,784     1,784    
Ending balance (in shares) at Mar. 31, 2025   25,845,000        
Ending Balance at Mar. 31, 2025 149,969 $ 258 $ (372,313) 346,639 (26,772) 202,157
Ending balance (in shares) at Mar. 31, 2025     (12,707,000)      
Beginning balance (in shares) at Dec. 31, 2024   25,713,000        
Beginning Balance at Dec. 31, 2024 $ 153,105 $ 257 $ (371,930) 344,697 (28,350) 208,431
Beginning balance (in shares) at Dec. 31, 2024 (12,666,443)   (12,666,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (17,515)          
Currency translation adjustment $ 6,629          
Purchase of treasury shares (in shares) (107,000)          
Purchase of treasury shares $ (780)          
Ending balance (in shares) at Sep. 30, 2025   26,138,000        
Ending Balance at Sep. 30, 2025 $ 146,145 $ 261 $ (372,710) 349,399 (21,721) 190,916
Ending balance (in shares) at Sep. 30, 2025 (12,772,743)   (12,773,000)      
Beginning balance (in shares) at Mar. 31, 2025   25,845,000        
Beginning Balance at Mar. 31, 2025 $ 149,969 $ 258 $ (372,313) 346,639 (26,772) 202,157
Beginning balance (in shares) at Mar. 31, 2025     (12,707,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,912)         (2,912)
Currency translation adjustment 4,245       4,245  
Shares issued for employee benefit plan and compensation (in shares)   197,000        
Shares issued for employee benefit plan and compensation 172 $ 2   170    
Purchase of treasury shares (in shares)     (60,000)      
Purchase of treasury shares (365)   $ (365)      
Shares issued to directors (in shares)   44,000        
Shares issued to directors 1 $ 1        
Employee and director stock-based compensation 1,649     1,649    
Ending balance (in shares) at Jun. 30, 2025   26,086,000        
Ending Balance at Jun. 30, 2025 152,759 $ 261 $ (372,678) 348,458 (22,527) 199,245
Ending balance (in shares) at Jun. 30, 2025     (12,767,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8,329)         (8,329)
Currency translation adjustment 806       806  
Shares issued for employee benefit plan and compensation (in shares)   35,000        
Shares issued for employee benefit plan and compensation 100     100    
Purchase of treasury shares (in shares)     (6,000)      
Purchase of treasury shares (32)   $ (32)      
Shares issued to directors (in shares)   17,000        
Shares issued to directors 0          
Employee and director stock-based compensation 841     841    
Ending balance (in shares) at Sep. 30, 2025   26,138,000        
Ending Balance at Sep. 30, 2025 $ 146,145 $ 261 $ (372,710) $ 349,399 $ (21,721) $ 190,916
Ending balance (in shares) at Sep. 30, 2025 (12,772,743)   (12,773,000)